Subgroups of multiple sclerosis patients with larger treatment benefits: a meta-analysis of randomized trials

Description

No subgroups of patients with higher treatment effects have been clearly detected in multiple sclerosis (MS). The aim of the present work was to evaluate whether there are subgroups of relapsing-remitting MS (RRMS) patients who are more responsive to treatments.

Additional details